Living in UK. After a MRI fusion guided biopsy..., (12 core samples..., 1 left side - no cancer, 3 right side - no cancer. Three selected targets - T1 - 4 samples - 1 cancer; T2 - 1 sample - no cancer; T3 - 3 samples - 3 cancers. Gleason 3+4 = 7. Noted as Grade 2 with Stage Rating T3a - N0 M0. Additional scans included 2 x mpMRI scans..., one body scan and an x-ray to check a spine anomaly - however, no other issues noted.
I commenced Hormone therapy Bicalutamide tabs 50mg, mid December for 3 weeks, and had my first (one month dose) of Leuprorelin (L) 3.75mg on 28th Dec 18. Received second L injection on 25th Jan 19 which was a 3 month dose.
My PSA had steadily increased from 24.6 in April 18 to 33.2 Dec 18 immediately prior to first L injection. At a meeting with medical team yesterday 20 Feb, they advised that my PSA level has now reduced to 3.1, which clearly is good news, and that they expect it to reduce further before my next L injection scheduled for May 19.
Next meeting is with RO in 3 weeks to discuss radiotherapy program which we hope to commence sometime in March/April, depending on PSA level.
Question..., whilst I appreciate everyone is different and treatment outcome varies, can I consider myself generally on track with this course of treatment?
Comments/pointers appreciated.